tiprankstipranks
Trending News
More News >
Moderna (MRNA)
NASDAQ:MRNA
US Market

Moderna (MRNA) Technical Analysis

Compare
17,141 Followers

Technical Sentiment

Overall Consensus
Neutral
8Bullish
5Neutral
9Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Sell
5Bullish
0Neutral
7Bearish
Moderna’s (MRNA) Moving Averages Convergence Divergence (MACD) indicator is -0.35, suggesting Moderna is a Sell.
Moderna’s (MRNA) 20-Day exponential moving average is 26.07, while Moderna’s (MRNA) share price is $26.26, making it a Buy.
Moderna’s (MRNA) 50-Day exponential moving average is 27.96, while Moderna’s (MRNA) share price is $26.26, making it a Sell.

Moderna (MRNA) Pivot Points

May 25, 2025, 08:07 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
23.99
24.61
25.66
26.28
27.33
27.95
29.00
Fibonacci
24.61
25.24
25.64
26.28
26.91
27.31
27.95
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Moderna (MRNA) Moving Averages

May 25, 2025, 08:07 PM
Period
Simple
Exponential
MA5
26.63Sell
26.25Buy
MA10
25.69Buy
25.99Buy
MA20
26.01Buy
26.07Buy
MA50
27.63Sell
27.96Sell
MA100
31.99Sell
34.11Sell
MA200
45.33Sell
53.30Sell
Moderna’s (MRNA) 10-Day exponential moving average is 25.99, while Moderna’s (MRNA) share price is $26.26, making it a Buy.
Moderna’s (MRNA) 100-Day exponential moving average is 34.11, while Moderna’s (MRNA) share price is $26.26, making it a Sell.
Moderna’s (MRNA) stock price is $26.26 and Moderna’s (MRNA) 50-day simple moving average is 27.63, creating a Sell signal.
Moderna’s (MRNA) stock price is $26.26 and Moderna’s (MRNA) 100-day simple moving average is 31.99, creating a Sell signal.
Moderna’s (MRNA) stock price is $26.26 and Moderna’s (MRNA) 200-day simple moving average is 45.33, creating a Sell signal.

Moderna (MRNA) Technical Indicators

May 25, 2025, 08:07 PM
Name
Value
Implied Action
RSI (14)
49.61
Neutral
STOCH (9,6)
43.46
Neutral
STOCHRSI (14)
43.46
Neutral
MACD (12,26)
-0.35
Sell
ADX (14)
15.52
Buy
Williams %R
-56.54
Buy
CCI (14)
0.89
Neutral
ATR (14)
1.82
-
Ultimate Oscillator
47.16
Neutral
ROC
-5.68
Sell
Moderna’s (MRNA) Relative Strength Index (RSI) is 49.61, creating a Neutral signal.
Moderna’s (MRNA) Trend Strength Indicator (ADX) is 15.52, creating a Buy signal.
Moderna’s (MRNA) Commodity Channel Index (CCI) is 0.89, creating a Neutral signal.
Moderna’s (MRNA) Price Rate of Change (ROC) is -5.68, creating a Sell signal.

FAQ

Is MRNA a Buy, Hold, or Sell?
Based on MRNA’s technical indicators, MRNA is a Hold.
    What is MRNA’s RSI (14)?
    MRNA’s RSI (14) is 49.61, which suggests MRNA is a Neutral.
      What is MRNA’s MACD?
      MRNA’s MACD is -0.35, which suggests MRNA is a Sell.
        What is MRNA’s 5-day moving average?
        MRNA’s 5-day moving average is 26.63, which suggests MRNA is a Sell.
          What is MRNA’s 20-day moving average?
          MRNA 20-day moving average is 26.01, which suggests MRNA is a Buy.
            What is MRNA’s 50-day moving average?
            MRNA’s 50-day moving average is 27.63, which suggests MRNA is a Sell.
              What is MRNA’s 200-day moving average?
              MRNA’s 200-day moving average is 45.33, which suggests MRNA is a Sell.
                What is MRNA’s Williams % R (14)?
                MRNA’s Williams % R (14) is -56.54, which suggests MRNA is a Buy.
                  What is MRNA’s CCI (14)?
                  MRNA’s CCI (14) is 0.89, which suggests MRNA is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis